Baird Maintains Outperform on Axonics, Raises Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Rescott maintains an Outperform rating on Axonics (NASDAQ:AXNX) and raises the price target from $69 to $70.
July 28, 2023 | 11:44 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst maintains an Outperform rating on Axonics and raises the price target to $70.
The news of Baird maintaining an Outperform rating and raising the price target for Axonics is likely to instill confidence in investors and could potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100